Technical Blog

Policy Analysis | New 2026 GMP Appendix on Pharmaceutical Packaging Materials Officially Takes Effect; Pharmaceutical Glass Industry Enters a New Phase of High-Quality Development

As of January 1, 2026, the Appendix on Pharmaceutical Packaging Materials in the “Good Manufacturing Practice for Pharmaceutical Products” issued by the National Medical Products Administration (NMPA) has been officially in effect for three months. Dubbed by the industry as the “strictest ever,” these GMP regulations for pharmaceutical packaging materials mark the official entry of China’s pharmaceutical packaging materials industry into a new phase of full-chain, end-to-end quality supervision.

Technology Frontiers | Accelerated Domestic Substitution of Medium-Borosilicate Glass Presents Opportunities for Structural Upgrades in the Pharmaceutical Glass Industry

In recent years, with the deepening implementation of associated review and approval policies and bioequivalence evaluations, China’s pharmaceutical glass industry has been undergoing profound transformation. Industry experts point out that the replacement of low-borosilicate glass with medium-borosilicate glass and the shift from imported to domestically produced products have become inevitable trends in the industry’s development.

Innovation-Driven | Backed by 26 Patented Technologies, Puyang Shixuan’s Smart Manufacturing Empowers Pharmaceutical Glass Production

Against the backdrop of accelerated transformation and upgrading in the pharmaceutical glass industry, technological innovation has become a key driver of core competitiveness for enterprises. Leveraging 26 patented technologies—covering feeding auxiliary devices, mold cooling systems, and high-efficiency sorting and packing equipment—Puyang Shixuan Pharmaceutical Glass Products Co., Ltd. has achieved full-process automation and intelligent upgrades in its production.